BOLDRIN, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 594
EU - Europa 121
AS - Asia 39
OC - Oceania 4
AF - Africa 1
Totale 759
Nazione #
US - Stati Uniti d'America 594
IT - Italia 75
CN - Cina 23
SG - Singapore 12
FI - Finlandia 9
GB - Regno Unito 8
SE - Svezia 8
DE - Germania 7
FR - Francia 6
AU - Australia 3
BG - Bulgaria 2
UA - Ucraina 2
BE - Belgio 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IN - India 1
JP - Giappone 1
NG - Nigeria 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
TH - Thailandia 1
Totale 759
Città #
Fairfield 110
Chandler 70
Houston 59
Woodbridge 59
Ashburn 50
Wilmington 44
Seattle 33
Cambridge 31
Ann Arbor 23
Des Moines 15
Milan 12
Padova 12
San Diego 10
Singapore 10
Beijing 9
Medford 7
Princeton 7
Rome 7
Boardman 6
Helsinki 6
Roxbury 6
Bari 4
Cagliari 4
Cellino Attanasio 3
Modena 3
Nanjing 3
Santa Clara 3
Biella 2
Catania 2
Edinburgh 2
Frankfurt am Main 2
Kharkiv 2
London 2
Nanchang 2
Naples 2
Oristano 2
Piove Di Sacco 2
Sarcedo 2
Sydney 2
Villanuova sul Clisi 2
Amsterdam 1
Bangkok 1
Bengaluru 1
Breganze 1
Brisbane 1
Brno 1
Brussels 1
Changsha 1
Dallas 1
Gunzenhausen 1
Hong Kong 1
Hounslow 1
Jiaxing 1
Lamezia Terme 1
Lekki 1
Munich 1
North Bergen 1
Paris 1
Shenyang 1
Tappahannock 1
Teramo 1
Tokyo 1
Washington 1
Totale 655
Nome #
Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus 163
Fast method for skeletal tissue gene expression analysis 132
Trapianto di cellule staminali in un modello animale di danno osseo da glucocorticoidi 106
Liquid biopsy as a novel tool to monitor the carcinogenesis of Barrett's esophagus 105
Allelic Imbalance Analysis in Liquid Biopsy to Monitor Locally Advanced Esophageal Cancer Patients During Treatment 91
Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study 85
Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma Patients 58
Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients 14
Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients 9
p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma 8
Totale 771
Categoria #
all - tutte 3.127
article - articoli 2.674
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.801


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020135 0 0 4 35 23 9 10 15 14 10 7 8
2020/2021141 2 15 1 30 2 19 19 9 10 9 20 5
2021/2022108 12 10 6 11 2 9 4 11 7 4 5 27
2022/2023146 20 16 2 24 20 26 4 8 13 4 8 1
2023/2024103 3 9 14 7 12 11 11 6 3 9 4 14
2024/202526 4 11 11 0 0 0 0 0 0 0 0 0
Totale 771